Latest News about CRL
Recent news which mentions CRL
These 21 large-cap stocks have now crashed at least 50%
April 26, 2022
From MarketWatch
Wells Fargo Maintains Overweight Rating for Charles River: Here's What You Need To Know
April 25, 2022
Tickers
CRL
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Monday
April 25, 2022
From Benzinga
From Benzinga
Markets Fall Amid Rising Oil Prices
March 23, 2022
From Benzinga
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
From InvestorPlace
Charles River Earnings Perspective: Return On Invested Capital
February 17, 2022
Tickers
CRL
From Benzinga
10 Biggest Price Target Changes For Thursday
February 17, 2022
From Benzinga
Earnings Scheduled For February 16, 2022
February 16, 2022
From Benzinga
From MarketWatch
Will Chart Analysts Notice Bad Omen on Charles River's Chart
January 07, 2022
Tickers
CRL
From Benzinga
Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm
December 08, 2021
From Benzinga
Charles River Laboratories International, inc (CRL) Q3 2021 Earnings Call Transcript
November 06, 2021
Tickers
CRL
From Motley Fool
Tickers
CRL
From Motley Fool
Charles River Posts Mixed Q3 Earnings; Narrows FY21 EPS Guidance
November 03, 2021
Tickers
CRL
From Benzinga
These high-flying stocks of 2021 have dropped the most today
September 28, 2021
From MarketWatch
7 Best Small Cap Stocks to Buy Heading Into Q4
September 13, 2021
From InvestorPlace
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
From Benzinga
You Won't Believe the Risk This Healthcare Company Faces
August 21, 2021
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
August 20, 2021
From Benzinga
Charles River Laboratories International, inc (CRL) Q2 2021 Earnings Call Transcript
August 04, 2021
Tickers
CRL
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.